Top Banner
CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT k.vanya
35

CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT k.vanya

Feb 24, 2016

Download

Documents

paytah

CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT k.vanya. Clinical features . Clinical features of B.anthracis:. Anthrax is a zoonotic disease. Anthrax “coal” ,comes from black colour of eschar - PowerPoint PPT Presentation
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

CLINICAL FEATURESEPIDEMIOLOGYLAB DIAGNOSISPROPHYLAXISTREATMENT

k.vanya

Page 2: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Clinical features

Page 3: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Clinical features of B.anthracis:Anthrax is a zoonotic disease.Anthrax “coal” ,comes from black

colour of escharRoute of infection: ingestion / inhalation of

spores /it may enter directly through skin.Infective material: discharges from mouth ,

nose &rectum of infected animals.The large no. of bacilli present in those

discharges sporulate in soil and remain as source of infection.

Direct spread from animal to animal is rare.

Page 4: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya
Page 5: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

it causes fatal septicemia, but some times it is localized/resemble cutaneous diseases in humans.

acquired from animals directly / indirectly.Based on clinical features, Anthrax is divided into 3 types

cutaneous pulmonary intestinal All these lead to fatal septicemia/meningitis

Page 6: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Cutaneous anthraxAlso called “hide porter’s disease”, as it is

common in dock workers,Route of infection: infection enter through

abraded skin.◦Also by shaving brushes made of animal hair

Usual sites: face,neck,hands,arms&back Lesion starts as papule 1-3 days after

infection

becomes vesicular (fluid clear/blood stained)

Page 7: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya
Page 8: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya
Page 9: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Malignant pustule:The whole area congested,

edematous & several satellite lesions filled with yellow fluid/serum arranged around central necrotic lesion which is covered by black eschar.

resolves spontaneously.Complications: 10-20% develop fatal

septicemia/meningitis

Page 10: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Malignant pustuleCongested

Edematous

Satellite lesions

Page 11: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Pulmonary anthraxAlso called “wool sorter’s disease”.Because it is common in wool

factories.Route of infection: due to inhalation

of dust from infected wool.More severe than others.Complications:

hemorrhagic pneumonia (common) hemorrhagic meningitis(rare)

Page 12: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya
Page 13: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Intestinal anthraxRareMainly in primitive communities

i.e. who eat dead bodies of animals died of anthrax.

Complication: violent enteritis with bloody

diarrhea with high fatality rate

Page 14: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya
Page 15: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

industrial Based on occupation non-industrial

Industrial: such as meat packing/wool factories.

Non-industrial: associated with animals(butchers

&farmers)

Page 16: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Rarely stomoxys calcitrans –biting insect transmit infection mechanically.

Page 17: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Epidemiology:Rare in western countriesLarge epidemics

russia&zimbabwe(1978-80)

Recently visakha agency has outbreaks of cutaneous anthrax

Andhra –tamilnadu region

Cutaneous,meningoencephalitic infections

Page 18: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Laboratory diagnosis

1)microscopy 2)culture

3)Animal inoculation 4)Serological

demonstration of anthrax Ag in

tissueType of test

based on availability

of specimens

Page 19: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Specimens: swab, fluid/pus from pustule-cutaneous anthrax

Sputum-pulmonary anthrax.Blood-septicemia anthrax.

Page 20: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Microscopy:Gram positive bacilli arranged in

large chains.

Page 21: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Capsule --Clear halo around bacillus in Indian ink preparation

Page 22: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Direct flourescent antibody test: capsule specific staining for poly saccharide Ag

Mc fadyean’s reaction :Amorphous purple material – characteristic of B.anthracis.

Employed for presumptive diagnosis in animals

Page 23: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Mc fadyean’s reaction

Page 24: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Culture : inoculated on nutrient agar incubate at 37 c for overnight.

-medusa head coloniesGelatin stab culture : inverted fir

tree

Page 25: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Animal inoculation : white mouse / guinea pigs injected with exudate /culture

Animal dies in 48 hrs

Page 26: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Serology ( Ascoli Thermo Precipitin Test ):

Tissues are ground up in saline and boiled for 5

mins and filtered. Then this extract layered over

anti anthrax serum in a narrow tube.

+ve case :ring of precipitate appears at junction of two liquids with in 5minutes.

mainly used for rapid diagnosis

when sample received is putrid and viable bacilli less likely found

Page 27: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

CDC(centers for disease control)guide lines:

Any large gram positive baciili with general morphology, cultural features of anthrax-non motile, on hemolytic on blood agar,catalase positive given presumptive report as anthrax.

Initial confirmation-lysis by gamma phage,DFA test.

Further confirmation:PCR test

Page 28: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Other methods :Polymerase chain reaction : used

for conformation of anthrax bacilli.

ELISA assay for antigen detectionX-ray and CT scanLysis by gamma phage

Page 29: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

PROPHYLAXIS:General methods : improvement of factory hygiene proper sterilization of animal

products , carcasses of animals suspected to have anthrax are buried deep in lime.

Page 30: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Active immunizationSpore is common infective formSterne vaccine contains spores of

non capsulated avirulent mutant strain

Animal is protected for a year with single injection of spore vaccine

Extensively used in animalsNot safe for human use

Page 31: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Contd….Alum precipitated toxoid

prepared from protective antigens used in persons occupationally exposed to anthrax infection.

Safe and effective in humansGiven in 3 doses IM at intervals

of 6 weeks

Page 32: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

Treatment:Before 2001, 1st line of treatment

was penicillin G◦ Stopped for fear of genetically

engineered resistant strains60 day course of antibioticsCiprofloxacin

◦ fluoroquinolone◦ 500 mg tablet every 12h or 400 mg

IV every 12h ◦ Inhibits DNA synthesis

Doxycycline◦ 6-deoxy-tetracycline◦ 100 mg tablet every 12h or 100 mg

IV every 12h ◦ Inhibits protein synthesis

Page 33: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

For inhalational, need another antimicrobial agent◦ clindamycin ◦ rifampin ◦ chloramphenicol

Anthrax infection gives permanent immunity&2nd attacks are rare.

Page 34: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya
Page 35: CLINICAL FEATURES EPIDEMIOLOGY LAB DIAGNOSIS PROPHYLAXIS TREATMENT          k.vanya

THANK YOU